mercredi 25 janvier 2017

Onco Actu du 25 janvier 2017


1. Biologie

How reproducible is basic lab research in cancer biology? [Science-Based Medicine]

1.1 Biologie - Gènes

Study reveals new genetic mechanism driving breast cancer [Sanger Institute]

TCGA study identifies genomic features of cervical cancer [NCI]

2.11 Etiologie - Alimentation

Warning over 'burnt toast chemical' acrylamide’s cancer risk [NHS Choices]

It’s too soon to say browned toast and crispy roast potatoes cause cancer [Cancer Research UK]

What is the real cancer risk from eating roast potatoes or toast? [The Guardian]

3.1 Tabac

Shifts Seen in Tobacco Product Types Purchased in US [NCI]

3.1.1 Tabac - e-cigs

E-Cigarettes may lure teens who otherwise might not smoke [Reuters]

4.2 Dép., diag. & prono. - Génome

Genetic Testing Offers New Hope for Children with Brain Cancer [MIT Technology Review]

5. Traitements

Study unveils new way to starve tumors to death [WUSTL]

Penn Researchers Help Unravel Mysteries of Pancreatic Cancer’s Resistance to Standard Therapies [Penn Medicine]

New insights into why breast cancer drugs fail for some women [NHS Choices]

5.10 Traitements - Essais

Study establishes new standard of care for pancreatic cancer patients [Cancer Research UK]

Trial finds combination of pancreatic cancer drugs extends survival [The Guardian]

5.12 Immunothérapies

Autoimmunity and cancer: Flip sides of the same coin? [Stanford Medicine]

Opdivo Making Strides in Advanced Hepatocellular Carcinoma [OBR Blog]

How Cancers Lose Something to Gain Immunotherapy Resistance [Cancer Research Catalyst]

5.12.5 Immunothérapies - Pharma

Armed with $16M, Cue Biopharma Aims for Selective Immunotherapy [Xconomy]

An upstart immunotherapy biotech emerges from stealth mode with big love for Kendall Square [EndPoints]

Novartis chases rivals with next wave of cancer immunotherapy [Reuters]

5.2 Pharma

Drug industry unveils massive new campaign to counter criticism [STAT]

Facing a deepening political crisis, PhRMA launches a major counterattack against its legion of critics [EndPoints]

5.3 Traitements - FDA, EMA, NICE...

I Do Hate To Tell You This, But. . . [In the Pipeline]

EMA Reflects on its First Decade of Conditional Marketing Authorizations [RAPS]

Conditional marketing authorisations give patients access to important new medicines earlier [EMA]

Keep Politics Out Of Science, Says Departing FDA Chief [Forbes]

Benefit-Risk Assessments at the US Food and Drug Administration [JAMA]

6.1 Observation

JAMA Study Reinforces that Cancer Prevention and Treatment Must Be Tailored by Region [ASCO]

Study Corrects Cancer Data and Finds Cervical Cancer Rates, Disparities Higher than Thought [ACS]

The risk of death from cancer may depend on where you live [Reuters]

6.10 Politiques

We must urgently clarify data-sharing rules [Nature]


6.11 Patients

High Anxiety Among Partners Of Young Breast Cancer Survivors, Study Finds [Forbes]

6.5 Médecines alternatives

Tackling cancer treatment myths, from clean eating to cannabis [The Guardian]

6.6 Publications

Journal retracts paper due to image mismatch; one co-author alleges fraud [Retraction Watch]

6.7 DMP, Big Data & applis

Digital Science Announces New Dimensions Module for Researchers, Providing Powerful Insights into the Global Funding Landscape [UberResearch]